期刊文献+

高校新生乙肝疫苗接种效果及影响因素分析

原文传递
导出
摘要 目的:观察某高校新生乙肝疫苗接种效果并分析影响因素。方法:选择肝功能正常的高校新生458例,采用0、1、6个月3针常规免疫程序接种乙肝疫苗,接种后90天采用ELISA法检测HBsAg和抗-HBs,根据抗-HBs检测结果分为疫苗应答组和无应答组。同时测定血糖、三酰甘油及总胆固醇水平,通过调查问卷,统计受试者的性别、年龄、身高、体重、既往疫苗接种史和各系统疾病的发病情况。结果:乙肝疫苗无应答者79例,发生率17.2%;无应答组男性比例、体重指数、吸烟率显著或非常显著高于应答组(P<0.05,P<0.01);Logistic回归分析结果显示,男性和体重指数进入乙肝疫苗无应答回归方程。结论:男性和体重指数是乙肝疫苗无应答的危险因素。
出处 《人民军医》 2011年第12期1052-1053,共2页 People's Military Surgeon
  • 相关文献

参考文献7

  • 1许露玫.乙肝疫苗应用的回顾与展望[J].河南医学研究,2000,9(1):88-89. 被引量:7
  • 2Fisman DN,Agrawal D, Leder K. The effect of age on immunologic response to recombinant hepatitis B vaccine:A Meta-analysis[J]. Clin Infect Dis,2002,35:1368- 1375.
  • 3Lee SS,Wong KH,Young BW. Children's age affects hepatitis B vaccine response [J]. Gastroenterol Hepatol,2003,18 : 750-751.
  • 4Jafarzadeh A,Shokri F. The antibody response to HBs antigen is regulated by coordinated Th1 and Th2 cytokine production in healthy neonates[J]. Clin Exp Immunol,2003,131:451-456.
  • 5Wood RC,MacDonald KL,Whire KE,et al. Risk factors for lack of detectable antibody following hepatitis B vaccination of Minnesota health care workers [J]. JAMA, 1993,270: 2935-2939.
  • 6Averhoff F, Mahoney F, Coleman, et al. Immunogenicity of hepatitis B Vaccines :Implications for persons at occupational risk of hepatitis B virus infection[J]. Am J Prey Med,1998,15(1):1-8.
  • 7中华医学会肝病学分会、中华医学会感染病分会和中国肝炎防治基金会.2010年更新版《慢性乙型肝炎防治指南》,2010.12.10.

二级参考文献12

  • 1Van Hattum J,Maikoet T, Pcel J,et al. Persistence d immune memory in responders to hepatitis B vaccination who subsequently lost anti-HBs titer[J].Hepatology,1990;12(7):885~889
  • 2Wands JR, Liang TS, Blum HE,et al. Molecular pathogenesis of liver disease during persistent hepatitis B virus infection[J]. Semin Liver Dis,1992;12(3):252~264
  • 3Creven DE,Awdeh ZL, Kunches LM,et al. Non-responsiveness to hepatitis B vaccine in health care workers: Results of revaccination and genetic typings [J].Ann Intern Med,1986,105(3):358~362
  • 4Katov WN,Dienstay JL. Prevention and therapy of viral hepatitis[J].Semin Liver Dis,1991;11(2):165~174
  • 5赵连三 基因疫苗.病毒相关性肝病防治的新希望见,病毒性肝炎的新治疗[J].中华肝脏病杂志,1999,7(1):48-49.
  • 6Davis HL, Michel ML, Whalon RG. DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high level of circulation antibody[J].Hum Mol Genet,1993;2(11):1847~1851
  • 7Michel ML, Davis HL, Schleef M, et al. DNA-mediated immunization to the hepatitis B surface antigen in mice: aspcts ct humoral response mice hepatitis B viral infection in humans[J].Proc Natl Acad Sci U S A,1995;92(12):5307~5311
  • 8Macini M,Davis HL, Schleef M,et al. Anti-hepatitis B immuneresponse induced through genetic inoculation in yiyo in HBsAg producing transgenic mice[J].12th. European Immnuology Meeting.Barcelona,1994;495
  • 9斯崇文,田庚善,巫善明,苏盛,封太昌,林秀玉,徐道振,周霞秋,张定凤,王兆荃,邬祥惠,仉洪田,朱理珉.三种疗法对慢性乙型肝炎的疗效观察[J].中华内科杂志,1997,36(10):661-664. 被引量:55
  • 10仝文斌,张春英,陶其敏.治疗性疫苗治疗慢性乙型肝炎的研究进展[J].临床肝胆病杂志,1998,14(2):71-72. 被引量:5

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部